Global Trade Alert
Global Trade Alert

Back to state act

United States of America: Agreement with Sanofi on Most-Favoured-Nation drug pricing and tariff exemption

Description

On 19 December 2025, the U.S. Administration announced an agreement with Sanofi. Under the agreement, Sanofi will be free from Section 232 tariffs on its imported products for three years, in exchange...

Sign in to see full description

Intervention Details

Intervention Type

Local operations incentive

MAST Chapter

I: Trade-related investment measures

Implementation date

No implementation date

Revocation date

No revocation date

Implementation level

National

Affected flow

Inward

Announced as temporary

No

Eligible firms

firm-specific

Affected Trading Partners

Graph

Table

Affected Sectors

Sign in to access 1 sectors

Affected Products

Sign in to access 5 products

Threads

See all

This intervention is not part of any Thread yet.